CA2023311A1 - Derives de furan - Google Patents

Derives de furan

Info

Publication number
CA2023311A1
CA2023311A1 CA2023311A CA2023311A CA2023311A1 CA 2023311 A1 CA2023311 A1 CA 2023311A1 CA 2023311 A CA2023311 A CA 2023311A CA 2023311 A CA2023311 A CA 2023311A CA 2023311 A1 CA2023311 A1 CA 2023311A1
Authority
CA
Canada
Prior art keywords
formula
hydrogen
gastrointestinal
furan derivatives
see formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2023311A
Other languages
English (en)
Other versions
CA2023311C (fr
Inventor
Setsuya Sasho
Shunji Ichikawa
Hiromasa Kato
Hiroyuki Obase
Katsuichi Shuto
Yoshimasa Oiji
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
KH Neochem Co Ltd
Original Assignee
Kyowa Hakko Kogyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyowa Hakko Kogyo Co Ltd filed Critical Kyowa Hakko Kogyo Co Ltd
Publication of CA2023311A1 publication Critical patent/CA2023311A1/fr
Application granted granted Critical
Publication of CA2023311C publication Critical patent/CA2023311C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nutrition Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Furan Compounds (AREA)
CA002023311A 1989-08-17 1990-08-15 Derives de furan Expired - Fee Related CA2023311C (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP1-211920 1989-08-17
JP21192089 1989-08-17

Publications (2)

Publication Number Publication Date
CA2023311A1 true CA2023311A1 (fr) 1991-02-18
CA2023311C CA2023311C (fr) 1999-11-02

Family

ID=16613857

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002023311A Expired - Fee Related CA2023311C (fr) 1989-08-17 1990-08-15 Derives de furan

Country Status (10)

Country Link
US (1) US5075301A (fr)
EP (1) EP0413343B1 (fr)
JP (1) JPH0730064B2 (fr)
AT (1) ATE125805T1 (fr)
CA (1) CA2023311C (fr)
DE (1) DE69021294T2 (fr)
DK (1) DK0413343T3 (fr)
ES (1) ES2075098T3 (fr)
GR (1) GR3017870T3 (fr)
HK (1) HK1006459A1 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9009437D0 (en) * 1990-04-26 1990-06-20 Glaxo Group Ltd Chemical compounds
US5338871A (en) * 1991-12-20 1994-08-16 Torcan Chemical Ltd. Preparation of form 1 ranitidine hydrochloride
DE69307310D1 (de) * 1992-05-12 1997-02-20 Zeria Pharm Co Ltd Neue quaternäre ammoniumsalze und deren medizinische verwendung
AU699008B2 (en) * 1995-05-18 1998-11-19 Zeria Pharmaceutical Co., Ltd. Aminothiazole derivative, medicament containing the same, and intermediate for preperation of said compound
ATE231137T1 (de) * 1996-10-24 2003-02-15 Zeria Pharm Co Ltd Substituierte benzoylthiazolderivate und sie enthaltende medikamente
US6152966A (en) * 1998-05-13 2000-11-28 Novo Nordisk A/S Treatment of cork with a phenol oxidizing enzyme
US6362205B2 (en) 1998-11-05 2002-03-26 Novo Nordisk A/S Substituted 3,3-diamino-2-propenenitriles, their preparation and use
AU6327199A (en) 1998-11-05 2000-05-29 Novo Nordisk A/S Substituted 3,3-diamino-2-propenenitriles, their preparation and use
US7977332B2 (en) * 2003-12-04 2011-07-12 Fmc Corporation Insecticidal N-(heteroarylalkyl)alkanediamine derivatives
CN111303087B (zh) * 2020-04-07 2021-08-10 自然资源部第三海洋研究所 呋喃酮类化合物及其制备方法与应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4048058A (en) * 1975-08-13 1977-09-13 Standard Oil Company (Indiana) Methods to be used in reforming processes employing multi-metallic catalysts
GB1565966A (en) * 1976-08-04 1980-04-23 Allen & Hanburys Ltd Aminoalkyl furan derivatives
FI832520L (fi) * 1982-07-12 1984-01-13 Bristol Myers Co Farmaceutiska foerfaranden och sammansaettningar
US4458077A (en) * 1982-11-22 1984-07-03 American Home Products Corporation Heterocyclic anti-ulcer agents
GB2209163B (en) * 1987-08-28 1991-04-24 Toyama Chemical Co Ltd Amine derivative and its salt, process for producing the same, and anti-ulcer agent containing the same

Also Published As

Publication number Publication date
CA2023311C (fr) 1999-11-02
JPH03163074A (ja) 1991-07-15
GR3017870T3 (en) 1996-01-31
ATE125805T1 (de) 1995-08-15
EP0413343A3 (en) 1992-04-22
JPH0730064B2 (ja) 1995-04-05
ES2075098T3 (es) 1995-10-01
US5075301A (en) 1991-12-24
EP0413343B1 (fr) 1995-08-02
DE69021294T2 (de) 1996-01-25
DK0413343T3 (da) 1995-12-11
HK1006459A1 (en) 1999-02-26
DE69021294D1 (de) 1995-09-07
EP0413343A2 (fr) 1991-02-20

Similar Documents

Publication Publication Date Title
TW349098B (en) Naphthalene derivatives, process for the preparation thereof, and intermediates therefor
CA2269053A1 (fr) Cristaux de derives benzimidazole et leur production
CA2078790A1 (fr) Analogues a base de 3-benzylidene-1-carbamoyl-2-pyrrolidone
AU666702B2 (en) Morphinan derivative and medicinal use
DE69303191T2 (de) Naphthalinderivate, ihre Herstellungsverfahren und synthetische Zwischenprodukte dafür
CA2023311A1 (fr) Derives de furan
ATE13178T1 (de) 2-oxoazetidin-derivate, ihre herstellung und verwendung.
IE890479L (en) Benzodioxoles
CA2020474A1 (fr) Compose anti-inflammatoire ou antiallergique
IE780119L (en) IMIDAZO(1,2-a) QUINOLINE-2-CARBOXYLIC ACIDS
CA2036977A1 (fr) Imidazopyridazines; preparation et utilisation
IL112102A0 (en) Annelated dihydropyridinoacetic acid derivatives, their preparation and pharmaceutical compositions containing them
CA2204204A1 (fr) Derives de glucides
EP0335979A4 (en) Thienopyrimidine derivatives
EP0230402A3 (en) Pharmacologically active alkylol derivatives
MY110683A (en) Ellipticine derivative and process for preparing the same
CA2118425A1 (fr) Derive du benzothiazolesulfamide, son mode de preparation et son utilisation
EP0721930A4 (fr) Derive du benzoylethylene
CA2056793A1 (fr) 5-amino-5,6,7,8-tetrahydroquinoleines et composes apparentes; methode de preparation et utilisation comme medicaments
CA2107675A1 (fr) Antibiotiques derives du carbapenem
CA2128202A1 (fr) Derives alkyles de la trazodone agissant sur le snc
KR960014780B1 (en) Dental plaque inhibitor composition and its preparation
IE850161L (en) Penem derivatives and azetidinone intermediates
CA2164152A1 (fr) Composes de la classe des secomacrolides et des secoazalides; methode de preparation
NO174886C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive pyrrolidin-derivater

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed